GME — Geratherm Medical AG Cashflow Statement
0.000.00%
- €12.12m
- €5.04m
- €14.87m
Annual cashflow statement for Geratherm Medical AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.333 | 1.08 | 1.67 | 0.654 | -0.828 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.396 | 0.844 | 0.321 | -4.01 | -0.138 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.42 | -0.618 | -2.23 | 2.97 | 1.11 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.917 | 2.79 | 1.47 | 1.47 | 1.3 |
| Capital Expenditures | -1.3 | -2.74 | -1.64 | -0.641 | -0.592 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.3 | 1.97 | -0.448 | 4.46 | 0.424 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.003 | -0.767 | -2.09 | 3.82 | -0.168 |
| Financing Cash Flow Items | -0.025 | -0.006 | -0.121 | -0.108 | -0.078 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.52 | 4.35 | -3.09 | -2.69 | -1.39 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.59 | 6.42 | -3.75 | 2.64 | -0.251 |